禾元生物:预计2025年年度实现营业收入4500万元到5000万元

Group 1 - The company, He Yuan Bio, announced an expected annual revenue for 2025 between 45 million to 50 million, representing a year-on-year increase of 78.46% to 98.29% [1] - The net profit attributable to the parent company is projected to be between -1.67 billion to -1.43 billion [1]

Wuhan Healthgen Biotechnology Corp.-禾元生物:预计2025年年度实现营业收入4500万元到5000万元 - Reportify